Analysis | Metabolite Name | Measured Value | Units | Organ | Cancer status | Smoker | Gender |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 59 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 84 | Peak area | Plasma | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 106 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 131 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 135 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 147 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 150 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 173 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 181 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 184 | Peak area | Serum | Adenocarcnoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 192 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 210 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 222 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 223 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 230 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 242 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 243 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 245 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 251 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 252 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 253 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 255 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 261 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 262 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 263 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 264 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 266 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 270 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 275 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 276 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 278 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 279 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 282 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 282 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 286 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 292 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 292 | Peak area | Serum | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 298 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 299 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 303 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 306 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 306 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 309 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 318 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 320 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 321 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 321 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 323 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 331 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 334 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 334 | Peak area | Serum | Adenosquamous | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 336 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 340 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 341 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 342 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 343 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 344 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 344 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 347 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 349 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 349 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 349 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 350 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 350 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 351 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 353 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 358 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 360 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 360 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 368 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 369 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 372 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 374 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 375 | Peak area | Plasma | Adenosquamous | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 377 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 379 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 383 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 386 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 389 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 389 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 390 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 391 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 396 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 397 | Peak area | Plasma | Adenosquamous | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 397 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 401 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 404 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 408 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 410 | Peak area | Serum | Adenosquamous | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 413 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 417 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 421 | Peak area | Plasma | Adenosquamous | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 424 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 425 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 428 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 429 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 430 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 434 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 434 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 439 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 439 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 443 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 443 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 444 | Peak area | Plasma | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 445 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 446 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 447 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 449 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 450 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 453 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 453 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 464 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 466 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 469 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 473 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 483 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 483 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 486 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 494 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 498 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 502 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 504 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 508 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 524 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 526 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 544 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 557 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 558 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 568 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 578 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 606 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 641 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 646 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 662 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 676 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 676 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 688 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 727 | Peak area | Serum | Adenocarcnoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 735 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 992 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1013 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1095 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1139 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1157 | Peak area | Serum | Adenosquamous | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1347 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1363 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1392 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1392 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1393 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1596 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1613 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1638 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1770 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1770 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1775 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1794 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1802 | Peak area | Plasma | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1804 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1816 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1831 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1856 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1864 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1943 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 1954 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2038 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2053 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2106 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2616 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2624 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2650 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2794 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2910 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2910 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2912 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 2972 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 3196 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 3225 | Peak area | Serum | Healthy | Former | F |